openPR Logo
Press release

Artificial Intelligence (AI) in HIV/AIDS Market Revenue, Region & Country Share, Trends, Growth Analysis Till 2030

09-05-2022 01:53 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Artificial Intelligence (AI) in HIV/AIDS Market

Artificial Intelligence (AI) in HIV/AIDS Market

The global Artificial Intelligence (AI) in HIV/AIDS market size is expected to reach USD 519.63 million by 2030 according to a new study by Polaris Market Research.

The report "Artificial Intelligence (AI) in HIV/AIDS Market Share, Size, Trends, Industry Analysis Report, By Tools (Machine Learning, Natural Language Processing, Image Processing, Speech Recognition, Others), By Data; By Types of Algorithms; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Request Sample Copy of Research Report @ https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-hiv-aids-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

The growing incidence of HIV/AIDS coupled with the increasing investment in R&D activities by the leading industry players are the prime factor for artificial intelligence in HIV/AIDS industry growth. Additionally, the rising penetration of ML (Machine Learning), NLP (Natural Language Processing), and other algorithms to apprehend complex health care data and proficient analysis is surging the industry demand.

Moreover, the integration of novel technologies and development in artificial intelligence (AI) technology aids in imaging & diagnostics, drug discovery, and many others and also offers a precise diagnosis of patient health status, augmenting the artificial intelligence (AI) in HIV and AIDS industry demand in the forecasting years.

Based on the tool, the machine learning segment is dominating the global artificial intelligence (AI) in HIV and AIDS industry with the highest revenue shares owing to the growing adoption of these technologies in healthcare settings, coupled with the increasing R&D activities for the advancements of ML is leading the segment growth.

Buy a Premium Report - https://www.polarismarketresearch.com/checkouts/12641

AIDS prevalence among the population is a significant health concern, which is directly associated with industry demand. The increasing patient poll of HIV patients leads to the surging demand for advanced intelligence technologies for HIV diagnostics. For instance, in 2016, nearly 36 million people were diagnosed with HIV around the world, subsequentially in which 2.1 million new cases were accounted with HIV infections as per the World Health Organization (WHO). Similarly, according to HIV.gov, in 2020, around 37.7 million people had HIV, with 1.5 million new cases. Thereby, raising the occurrence of HIV is propelling the industry's demand globally.

Market participants such as Google Inc., Johnson & Johnson Services Inc., Microsoft Corporation, Siemens Healthineers AG, Intel Corporation, Koninklijke Philips N.V., General Electric Healthcare, Medtronic plc, Amazon Web Services, IBM, General Vision Inc., and NVIDIA Corporation are some of the key players operating in the global market.

Inquire more about this report before purchasing @ https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-hiv-aids-market/inquire-before-buying

(You may enquire about a reported quote OR available discount offers to our sales team before purchase.)

Polaris Market Research has segmented the Artificial Intelligence (AI) in HIV/AIDS market report based on component, solution, payload, application, and region:

AI in HIV/AIDS, Tool Outlook (Revenue - USD Million, 2018 - 2030)
• Machine Learning
• Natural Language Processing
• Image Processing
• Speech Recognition
• Others

AI in HIV/AIDS, Data Outlook (Revenue - USD Million, 2018 - 2030)
• Patient Data
• Insurance Information
• Hospital Stay

AI in HIV/AIDS, Types of Algorithm Outlook (Revenue - USD Million, 2018 - 2030)
• Artificial Neural Networks
• Deep Learning
• Others

Browse detailed report with in-depth TOC - https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-hiv-aids-market

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Intelligence (AI) in HIV/AIDS Market Revenue, Region & Country Share, Trends, Growth Analysis Till 2030 here

News-ID: 2724284 • Views:

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected to
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways